Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules.
Choi JY, Lee YJ, Ko JH, Kim SH, Kim HJ, Lee HW, Jeong H, Kim TY, Jang YG, Hong HJ, Kim MS, Lee SE, Kim YG, Chung EJ, Lim H, Jang S, Kim K, Kim SS, Ahn JY, Choi JY, Kim YC, Park YS, Peck KR, Kim B.
Choi JY, et al. Among authors: lee hw, lee yj, lee se.
Front Cell Infect Microbiol. 2022 Jul 11;12:948014. doi: 10.3389/fcimb.2022.948014. eCollection 2022.
Front Cell Infect Microbiol. 2022.
PMID: 35899050
Free PMC article.